Daphne S. Mous

Congenital Diaphragmatic Hernia and Growth to 12 Years

Lisette Leeuwen, Daphne S. Mous, Joost van Rosmalen et al. · PEDIATRICS · 2017 · 45 citations · Full text

Clinically relevant timing of antenatal sildenafil treatment reduces pulmonary vascular remodeling in congenital diaphragmatic hernia

Daphne S. Mous, Heleen Kool, Marjon J. Buscop-van Kempen et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2016 · 41 citations

Attenuated <scp>PDGF</scp> signaling drives alveolar and microvascular defects in neonatal chronic lung disease

Prajakta Oak, Tina Pritzke, Isabella Thiel et al. · EMBO Molecular Medicine · 2017 · 40 citations · Full text

Changes in vasoactive pathways in congenital diaphragmatic hernia associated pulmonary hypertension explain unresponsiveness to pharmacotherapy

Daphne S. Mous, Marjon J. Buscop-van Kempen, René Wijnen et al. · Respiratory Research · 2017 · 34 citations · Full text

Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag’s active compound, at the pseudoglandular stage improves lung vasculature

Daphne S. Mous, Heleen Kool, Petra E. Bürgisser et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2018 · 31 citations · Full text

Pseudoglandular Stage, Hypertension, Pulmonary Arterial Hypertension +12